Detalhe da pesquisa
1.
MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum.
PLoS Pathog
; 17(2): e1009283, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33534834
2.
Oncolytic Foamy Virus - generation and properties of a nonpathogenic replicating retroviral vector system that targets chronically proliferating cancer cells.
J Virol
; 95(10)2021 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33692205
3.
MicroRNA-Detargeted Mengovirus for Oncolytic Virotherapy.
J Virol
; 90(8): 4078-4092, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26865716
4.
Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular Carcinoma.
Hum Mutat
; 37(10): 1097-105, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27397503
5.
Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity.
mBio
; 15(2): e0292823, 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38193729
6.
Polycytidine tract deletion from microRNA-detargeted oncolytic Mengovirus optimizes the therapeutic index in a murine multiple myeloma model.
Mol Ther Oncolytics
; 28: 15-30, 2023 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36619293
7.
Evaluation of the stability and intratumoral delivery of foreign transgenes encoded by an oncolytic Foamy Virus vector.
Cancer Gene Ther
; 29(8-9): 1240-1251, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35145270
8.
Surface-modified measles vaccines encoding oligomeric, fusion-stabilized SARS-CoV-2 spike glycoproteins bypass measles seropositivity, boosting neutralizing antibody responses to omicron and historical variants.
bioRxiv
; 2022 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36561187
9.
MicroRNA-detargeting proves more effective than leader gene deletion for improving safety of oncolytic Mengovirus in a nude mouse model.
Mol Ther Oncolytics
; 23: 1-13, 2021 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34589580
10.
Serotypic evolution of measles virus is constrained by multiple co-dominant B cell epitopes on its surface glycoproteins.
Cell Rep Med
; 2(4): 100225, 2021 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33948566
11.
Unlocking loxP to Track Genome Editing In Vivo.
Genes (Basel)
; 12(8)2021 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34440379
12.
Oncolytic Activity of Targeted Picornaviruses Formulated as Synthetic Infectious RNA.
Mol Ther Oncolytics
; 17: 484-495, 2020 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32529026
13.
Retargeted and Stealth-Modified Oncolytic Measles Viruses for Systemic Cancer Therapy in Measles Immune Patients.
Mol Cancer Ther
; 19(10): 2057-2067, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32847970
14.
Generation of a Tumor-Specific Chemokine Gradient Using Oncolytic Vesicular Stomatitis Virus Encoding CXCL9.
Mol Ther Oncolytics
; 16: 63-74, 2020 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31930167
15.
Oncolytic vesicular stomatitis virus and bortezomib are antagonistic against myeloma cells in vitro but have additive anti-myeloma activity in vivo.
Exp Hematol
; 41(12): 1038-49, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24067362